These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 10566810)

  • 1. Preclinical study in cats of the pro-photosensitizer 5-aminolevulinic acid.
    Lucroy MD; Edwards BF; Peavy GM; Krasieva TB; Griffey SM; Stiles JB; Madewell BR
    Am J Vet Res; 1999 Nov; 60(11):1364-70. PubMed ID: 10566810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protoporphyrin IX fluorescence induced in basal cell carcinoma by oral delta-aminolevulinic acid.
    Tope WD; Ross EV; Kollias N; Martin A; Gillies R; Anderson RR
    Photochem Photobiol; 1998 Feb; 67(2):249-55. PubMed ID: 9487802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the pharmacokinetics and phototoxicity of protoporphyrin IX metabolized from 5-aminolevulinic acid and two derivatives in human skin in vivo.
    Gerscher S; Connelly JP; Griffiths J; Brown SB; MacRobert AJ; Wong G; Rhodes LE
    Photochem Photobiol; 2000 Oct; 72(4):569-74. PubMed ID: 11045731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of the photosensitizers aminolevulinic acid and aminolevulinic acid hexylester in oro-facial tumors embedded in the chorioallantois membrane of a hen's egg.
    Hoppenheit C; Hüttenberger D; Foth HJ; Spitzer WJ; Reichert TE; Müller-Richter UD
    Cancer Biother Radiopharm; 2006 Dec; 21(6):569-78. PubMed ID: 17257072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fluorescence biodistribution and kinetics of aminolevulinic acid induced protoporphyrin IX in the bladder of a rat model with orthotopic urothelial carcinoma.
    Gronlund-Pakkanen S; Wahlfors J; Makinen K; Pakkanen TM; Talja M; Ala-Opas M; Alhava E; Moore RB
    J Urol; 2002 Apr; 167(4):1848-53. PubMed ID: 11912446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The monitoring of the accumulation of protoporphyrin IX in Walker tumours by subcutaneous administration of delta-aminolevulinic acid.
    Calin MA; Gruia Ml; Herascu N; Coman T
    J Exp Ther Oncol; 2004 Oct; 4(3):247-51. PubMed ID: 15724844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A HCl/alcohol formulation increased 5-aminolevulinic acid skin distribution using an ex vivo full thickness porcine skin model.
    Maisch T; Worlicek C; Babilas P; Landthaler M; Szeimies RM
    Exp Dermatol; 2008 Oct; 17(10):813-20. PubMed ID: 18380780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of early stages of carcinogenesis in adenomas of murine lung by 5-aminolevulinic acid-induced protoporphyrin IX fluorescence.
    Campbell DL; Gudgin-Dickson EF; Forkert PG; Pottier RH; Kennedy JC
    Photochem Photobiol; 1996 Oct; 64(4):676-82. PubMed ID: 8863473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protoporphyrin IX-accumulation in human tumor cells following topical ALA- and h-ALA-application in vivo.
    Zenzen V; Zankl H
    Cancer Lett; 2003 Dec; 202(1):35-42. PubMed ID: 14643024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing desferrioxamine and light fractionation enhancement of ALA-PpIX photodynamic therapy in skin cancer.
    de Souza AL; Marra K; Gunn J; Samkoe KS; Kanick SC; Davis SC; Chapman MS; Maytin EV; Hasan T; Pogue BW
    Br J Cancer; 2016 Sep; 115(7):805-13. PubMed ID: 27575852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometry study of the role of superoxide anion and hydrogen peroxide in cellular photodestruction with 5-aminolevulinic acid-induced protoporphyrin IX.
    Gilaberte Y; Pereboom D; Carapeto FJ; Alda JO
    Photodermatol Photoimmunol Photomed; 1997; 13(1-2):43-9. PubMed ID: 9361128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro/in vivo correlations between transdermal delivery of 5-aminolaevulinic acid and cutaneous protoporphyrin IX accumulation and effect of formulation.
    Tsai JC; Chen IH; Wong TW; Lo YL
    Br J Dermatol; 2002 May; 146(5):853-62. PubMed ID: 12000384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and pharmacological modification of resistance mechanisms to protoporphyrin-mediated photodynamic therapy in human cutaneous squamous cell carcinoma cell lines.
    Schary N; Novak B; Kämper L; Yousf A; Lübbert H
    Photodiagnosis Photodyn Ther; 2022 Sep; 39():103004. PubMed ID: 35811052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etretinate enhances the susceptibility of human skin squamous cell carcinoma cells to 5-aminolaevulic acid-based photodynamic therapy.
    Ishida N; Watanabe D; Akita Y; Nakano A; Yamashita N; Kuhara T; Yanagishita T; Takeo T; Tamada Y; Matsumoto Y
    Clin Exp Dermatol; 2009 Apr; 34(3):385-9. PubMed ID: 19077103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics and localisation of PpIX fluorescence after topical and systemic ALA application, observed in skin and skin tumours of UVB-treated mice.
    van der Veen N; de Bruijn HS; Berg RJ; Star WM
    Br J Cancer; 1996 Apr; 73(7):925-30. PubMed ID: 8611408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of (R)L-sulforaphane on 5-aminolevulinic acid-mediated photodynamic therapy.
    Mikolajewska P; Juzeniene A; Moan J
    Transl Res; 2008 Sep; 152(3):128-33. PubMed ID: 18774542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo pharmacokinetics of protoporphyrin IX accumulation following intracutaneous injection of 5-aminolevulinic acid.
    de Blois AW; Thissen MR; de Bruijn HS; Grouls RJ; Dutrieux RP; Robinson DJ; Neumann HA
    J Photochem Photobiol B; 2001 Aug; 61(1-2):21-9. PubMed ID: 11485844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodistribution of protoporphyrin IX in rat urinary bladder after intravesical instillation of 5-aminolevulinic acid.
    Chang SC; MacRobert AJ; Bown SG
    J Urol; 1996 May; 155(5):1744-8. PubMed ID: 8627876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence detection and depletion of T47D breast cancer cells from human mononuclear cell-enriched blood preparations by photodynamic treatment: Basic in vitro experiments towards the removal of circulating tumor cells.
    Ziegler VG; Knaup J; Stahl D; Krammer B; Plaetzer K
    Lasers Surg Med; 2011 Sep; 43(7):548-56. PubMed ID: 22057482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro comparison of hypericin and 5-aminolevulinic acid-derived protoporphyrin IX for photodynamic inactivation of medulloblastoma cells.
    Ritz R; Scheidle C; Noell S; Roser F; Schenk M; Dietz K; Strauss WS
    PLoS One; 2012; 7(12):e51974. PubMed ID: 23251668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.